Literature DB >> 25455

Prolactin secretion during and after Noveril infusions to depressive patients.

U Halbreich, M Assael, M Ben-David.   

Abstract

Dibenzapine (720 mg, Noveril) was infused intravenously to 16 depressed patients during a period of 3 h. Serum prolactin levels were determined by radioimmunoassay and changes in clinical condition were evaluated according to the Hamilton Equation. The two variables were correlated to each other. In most of the patients Noveril caused a dramatic but short-lived improvement in depressive symptoms. There was much variability in the prolactin response to the drug. Serum prolactin levels showed a great elevation in 9 patients. In all patients the hormonal levels returned to their former normal levels after termination of the infusions. The treatment was then continued with Noveril per os. There was no significant correlation between serum prolactin levels and clinical condition or its change. The elevation of serum prolactin levels as a reaction to Noveril treatment may be explained by the prominent serotonergic action of Noveril. A time lag between serotonergic and dopaminergic actions of the drug when given in higher doses may be an additional explanation. Other possible hypotheses are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25455     DOI: 10.1007/BF00431844

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

Review 1.  Prolactin and mental illness.

Authors:  D F Horrobin; J P Mtabaji; R A Karmali; M S Manku; B A Nassar
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

2.  [A PHARMACOLOGIC COMPARISON OF CLINICALLY USED ANTIDEPRESSIVE AGENTS WITH SPECIAL REFERENCE TO NOVERIL (HF-1927 WANDER)].

Authors:  G STILLE; H LAUENER; E EICHENBERGER
Journal:  Schweiz Med Wochenschr       Date:  1965-03-13

3.  Plasma prolactin concentrations in patients on clomipramine.

Authors:  E N Cole; G V Groom; J Link; P M O'Flanagan; J Seldrup
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

4.  The effect of clomipramine on prolactin levels--pilot studies.

Authors:  A F Francis; P Williams; R Williams; J Link; E N Cole; D Hughes
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

5.  Growth hormone and prolactin in unipolar and bipolar depressed patients: responses to hypoglycemia and L-dopa.

Authors:  E J Sachar; A G Frantz; N Altman; J Sassin
Journal:  Am J Psychiatry       Date:  1973-12       Impact factor: 18.112

6.  Human prolactin and growth hormone release during surgery and other conditions of stress.

Authors:  G L Noel; H K Suh; J G Stone; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

7.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

8.  Serum-prolatic in women with premenstrual syndrome.

Authors:  U Halbreich; M Ben-David; M Assael; R Bornstein
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

  8 in total
  2 in total

Review 1.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant.

Authors:  H Y Meltzer; M Young; J Metz; V S Fang; P M Schyve; R C Arora
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.